“Anhedonia” seen in schizophrenia is linked to which of the following neurotransmitter abnormality?
**Core Concept**
Anhedonia, a core symptom of schizophrenia, refers to the inability to experience pleasure from activities usually found enjoyable. It is closely linked to the dysfunction of certain neurotransmitter systems in the brain.
**Why the Correct Answer is Right**
The correct answer is linked to the dopamine system, particularly the mesolimbic pathway. The mesolimbic dopamine pathway is involved in the regulation of motivation, pleasure, and reward processing. Anhedonia in schizophrenia is thought to be related to the overactivity of this pathway, which leads to an excessive release of dopamine. This overactivity is believed to be responsible for the positive symptoms of schizophrenia, including hallucinations and delusions. The blockade of dopamine receptors, particularly D2 receptors, by antipsychotic medications can help alleviate anhedonia and other positive symptoms.
**Why Each Wrong Option is Incorrect**
**Option A:** Serotonin is involved in mood regulation and is often targeted in the treatment of depression, but it is not directly linked to anhedonia in schizophrenia.
**Option B:** Glutamate is an excitatory neurotransmitter involved in learning and memory, but it is not directly associated with anhedonia in schizophrenia.
**Option C:** GABA is an inhibitory neurotransmitter that helps regulate the activity of neurons, but it is not directly linked to anhedonia in schizophrenia.
**Clinical Pearl / High-Yield Fact**
It's essential to remember that anhedonia is a common feature of schizophrenia and can be a key indicator of the disease. Antipsychotic medications that block dopamine receptors can help alleviate anhedonia, but they may also have side effects such as extrapyramidal symptoms.
**Correct Answer:** C.